share_log

シンバイオ製薬:注射剤ブリンシドフォビルによる第2a相臨床試験(ATHENA試験)における造血幹細胞移植後のサイトメガロウイルス感染症を対象とした臨床試験開始のお知らせ

SymBio Pharmaceuticals: Notice of commencement of clinical trials targeting cytomegalovirus infection after hematopoietic stem cell transplantation in a phase 2a clinical trial (ATHENA trial) with the injectable brincidofovir

JPX ·  May 8 03:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more